Chugai's Alecensa® Met Its Primary Endpoint in the ALEX Study

Go back to Chugai's Alecensa® Met Its Primary Endpoint in the ALEX Study
Chugai Pharmaceutical Ltd Unsponsored ADR (AMEX: CHGCY) Delayed: 22.09 -0.01 (0.05%)
Previous Close $22.10    52 Week High $74.63 
Open $21.84    52 Week Low $56.80 
Day High $22.25    P/E N/A 
Day Low $21.53    EPS $0.00 
Volume 240,126       

Roche Holding AG Basel American Depositary Shares (AMEX: RHHBY) Delayed: 57.25 -0.95 (1.63%)
Previous Close $58.20    52 Week High $35.13 
Open $57.94    52 Week Low $28.10 
Day High $58.28    P/E N/A 
Day Low $57.00    EPS $0.00 
Volume 5,374,315       

Brown & Brown, Inc. (NYSE: RO) Delayed: 8.49 +0.55 (6.93%)
Previous Close $7.94    52 Week High $8.59 
Open $7.94    52 Week Low $7.82 
Day High $8.59    P/E 6.53 
Day Low $7.82    EPS $1.30 
Volume 42,732